Natural Killer Cells and Immunotherapy

Natural Killer Cells and Immunotherapy

Natural killer (NK) cells are innate immune cells that demonstrate cytolytic activity against tumor cells, virus-infected cells and other physiologically stressed cells, such as senescent cells [...]

Bibliographic Details
Main Authors:	Ji-Yoon Noh, Haiyoung Jung
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	International Journal of Molecular Sciences
Subjects:	n/a
Online Access:	https://www.mdpi.com/1422-0067/24/10/8760

Similar Items

Special Issue “New Developments in Natural Killer Cells for Immunotherapy”
by: Jacques Zimmer, et al.
Published: (2023-05-01)

Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes
by: Isabel Legaz, et al.
Published: (2023-04-01)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
by: Ji-Yoon Noh, et al.
Published: (2020-10-01)

Natural Killer T Cell Diversity and Immunotherapy
by: Eduardo I. Tognarelli, et al.
Published: (2023-12-01)

Natural killer cells in tumor immunotherapy
by: Dongyao Wang, et al.
Published: (2023-08-01)

Natural killer cell immunotherapy in glioblastoma
by: Hamed Hosseinalizadeh, et al.
Published: (2022-10-01)

Natural Killer T Cells in Cancer Immunotherapy
by: Shiny Nair, et al.
Published: (2017-09-01)

Killer instincts: natural killer cells as multifactorial cancer immunotherapy
by: Sarah Nersesian, et al.
Published: (2023-11-01)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
by: Tomonori Iyoda, et al.
Published: (2023-02-01)

Nutraceuticals to Mitigate the Secret Killers in Animals
by: Guillermo Tellez-Isaias, et al.
Published: (2022-08-01)

Unpacking the Complexities of a Silent Killer
by: Dai Yamanouchi
Published: (2023-04-01)

Recent Advances in the Yeast Killer Systems Research
by: Elena Servienė, et al.
Published: (2023-05-01)

Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivo
by: Arum Park, et al.
Published: (2022-08-01)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
by: Mireia Bachiller, et al.
Published: (2020-10-01)

Natural Killer Cell-Mediated Immunotherapy for Leukemia
by: Michaela Allison, et al.
Published: (2022-02-01)

In vitro Natural Killer cell immunotherapy for medulloblastoma
by: Lucia eFernandez, et al.
Published: (2013-04-01)

Targeting Natural Killer Cells for Tumor Immunotherapy
by: Cai Zhang, et al.
Published: (2020-02-01)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
by: Samantha A. Barnes, et al.
Published: (2021-10-01)

Immunogenic Cell Stress and Death Sensitize Tumors to Immunotherapy
by: Oliver Kepp, et al.
Published: (2023-12-01)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
by: Takayuki Morimoto, et al.
Published: (2023-01-01)

Natural killer cells: the next wave in cancer immunotherapy
by: Xin Chen, et al.
Published: (2022-07-01)

Natural killer cells: a promising immunotherapy for cancer
by: Junfeng Chu, et al.
Published: (2022-05-01)

Next Generation Natural Killer Cells for Cancer Immunotherapy
by: Fiorella Rossi, et al.
Published: (2022-06-01)

New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
by: Luc Teyton
Published: (2017-11-01)

Updating targets for natural killer/T-cell lymphoma immunotherapy
by: Weili Xue, et al.
Published: (2021-02-01)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
by: William C. Kisseberth, et al.
Published: (2021-06-01)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
by: Kari A. Shaver, et al.
Published: (2021-04-01)

Natural killer cell immunotherapy: from bench to bedside
by: Anna eDomogala, et al.
Published: (2015-06-01)

Natural killer cels in immunotherapy for cancer
by: E. A. Borobova, et al.
Published: (2019-01-01)

Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy
by: Jin-Ho Choi, et al.
Published: (2022-08-01)

Targeted Immunotherapies for Cancers
by: Anthony Cheung, et al.
Published: (2023-12-01)

The Renewal of Cancer Immunotherapy
by: Jenny Bulgarelli, et al.
Published: (2023-03-01)

Immunotherapy for Solid Tumors
by: Hortense de Saint Basile, et al.
Published: (2023-03-01)

Oncolytic Virus Immunotherapy
by: Antonio Marchini, et al.
Published: (2021-07-01)

Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
by: Vita Golubovskaya
Published: (2023-10-01)

T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
by: Paola Fisicaro, et al.
Published: (2022-01-01)

Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors
by: Pierre Tennstedt, et al.
Published: (2023-05-01)

Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
by: Hyunmin Chung, et al.
Published: (2021-11-01)

Harnessing the power of invariant natural killer T cells in cancer immunotherapy
by: Bedard, M, et al.
Published: (2017)

Ovarian cancer treatment and natural killer cell-based immunotherapy
by: Zhongru Fan, et al.
Published: (2023-12-01)